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ABSTRACT 
 
BACKGROUND: Many of the pathogenic effects of Helicobacter pylori infection are related
 
to chronic 
active inflammation, which is controlled and maintained
 










In Africa, the data are scarce regarding the effects of these 
polymorphisms on gastric pathology. The objective of this study is therefore to investigate the pro-
inflammatory genetic polymorphisms and their role in H. pylori-related gastric disorders
 
in a select 
African population.  
METHODS: This cross-sectional prospective study recruited six hundred and ninety six adult subjects 
with a history of uninvestigated dyspepsia. The H. pylori status was determined by tissue Giemsa 
staining, Rapid Urease Test (RUT), H. pylori stool antigen test (HpSAT), and PCR using the 16s-rRNA 
gene. The polymorphisms in IL-1B (511 C/T), TNF-A (_308 G/A) and IL-1RN were assessed by the PCR-
restricted fragment length polymorphism (RFLP). 
RESULTS: H. pylori was significantly associated with gastric pathologies investigated (P ═ 0.0000). 
Heterozygous allele TC of IL-1 β -511 was significantly associated with H. pylori infection (p = 
0.003815). Similarly, allele IL-1 RN*2/2 and allele IL-1 RN-L/L were associated with H. pylori infection 
(p = 0.0025 and p = 0.0203). Allele T of IL-1 β -511 and IL-1 RN-L/L are more frequent in H. pylori 
associated gastric pathologies in this series. 
CONCLUSION: Allele T of IL-1 β -511 and long allele IL-1 RN-L/L play a role in H. pylori disease in 
this population. 
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INTRODUCTION                                                                                                  
 
Since the discovery of Helicobacter pylori (H. 
pylori) (1) and its subsequent association with 
upper gastrointestinal (UGI) pathologies (2, 3, 4), 
a ripple effect has been observed which has 
resulted in new insights into the impact of the 
bacterium on the pathology and physiology of the 
stomach (5). Of particular concern to Africa is 
the perception that H. pylori infections in Africa 
are at odds in several aspects with those in the 
west (6, 7).  
The level of gastric acid secretion and the
 
presence 
of a pro-inflammatory response contribute 
significantly
 
to the development of either duodenal 
ulcer disease or atrophic
 
gastritis. Importantly is 
the interleukin-1 (IL-1) cytokine which is encoded 
by a gene cluster
 
that contains the polymorphic IL-
1B (encoding the IL-1ß
 
cytokine) and IL-RN 
(encoding the IL-1 receptor antagonist)
 
genes. IL-
1ß is a potent pro-inflammatory cytokine
 
and the 
most potent known inhibitor of acid secretion (8).
 




and IL-1RN*2/2, which lead to high-level
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expression of IL-1ß. This subsequently leads to 
reduced
 
acid output, which is associated with 
corpus-predominant colonization
 
by H. pylori, 
resulting in pangastritis, formation of atrophic
 
gastritis, and increased risk of gastric cancer (9, 8, 
10, 11, 12, 13). 
 Similar effects have been observed for genes 
encoding
 
tumor necrosis factor alpha (TNF- ) and 
IL-10. The TNF-A-308A genotype is associated 
with increased TNF-  production,
 
which, together 
with IL-1, influences gastrin production and
 
thus 
acid production by gastric parietal cells (14). The 
TNF-A-308A
 
genotype is therefore associated 
with H. pylori infection and
 
increased risk of 
gastric cancer (10, 15, 16, 17, 18).
 
Similarly, 
expression of the anti-inflammatory cytokine IL-
10
 
is affected by the haplotypes described for the 
IL-10 gene.
 
The GCC haplotype is associated with 
a higher expression level
 
of IL-10 and hence 
favors an anti-inflammatory response, whereas
 
the 
ATA haplotype results in lowered IL-10 levels 
and a shift
 
toward a proinflammatory response (10, 
19, 16, 18). The GCC haplotype is associated with 
colonization
 
with more-virulent H. pylori strains 
(16), whereas the ATA
 
haplotype is associated 
with increased risk of gastric cancer
 




shown that while single polymorphisms may 
increase
 
the risk of development of gastric cancer 
only two- to threefold,
 




substantially (10, 11, 12, 16, 18).
 
 
The interaction between the different
 
pro- and 
anti-inflammatory polymorphisms, the immune 
status
 
of the host, and the characteristics of the 
colonizing H. pylori
 
strain jointly determine 
disease outcome (13).
 
In Africa, the data are scarce 
regarding the effects of these polymorphisms on 
gastric pathology. This study is therefore 
conducted to investigate the pro-inflammatory 
genetic polymorphisms and their role in H. pylori-
related gastric disorders
 
in a select African 
population.  
 
MATERIALS AND METHODS 
 
Study Population: Six hundred and ninety six 
patients presenting with dyspepsia at the 
gastroenterology clinic of the Aga Khan 
University Hospital, Nairobi and who had been 
referred for endoscopy were recruited. Approval 
was obtained from the ethical board of the 
university, and the study conducted according to 
the ethical guidelines of the declaration of 
Helsinki as revised in 2000 (20). All subjects 
provided written informed consent before 
entering the study. All of the above patients were 
screened for H. pylori. Two hundred and ninety 
(41.6%) were randomly selected for pro-
inflammatory cytokine studies. 
Sample collection: For each of the patient, 6 
gastric biopsy specimens were obtained for 
histological evaluation, DNA extraction, and H. 
pylori detection. Four biopsies were obtained 
from incisura angularis and two from the pre-
pyloric region. Biopsies for histological 
evaluation were transported to the laboratory 
submerged in formalin, in the laboratory, they 
were fixed and paraffin embedded. An 
experienced pathologist examined and reported 
the findings from all the histological slides. 
Those intended for DNA extraction were 
immediately submerged in 5% Brain Heart 
Infusion (BHI) agar enriched with 7% Fetal 
Bovine Serum (FBS) upon extraction and stored 
in deep freezer (-80
0
C) till processing 
H. pylori status: The H. pylori status of the study 
population was determined by tissue Giemsa 
staining, the Rapid Urease Test (RUT), H. pylori 
stool antigen test (HpSAT), and by PCR using the 
C97-20 and H3A-20 primers for the 16s-rRNA 
gene (F-GGCTATGACGGGTATCCGGC, R-
GCCGTGCAGCACCTGTTTTC). PCR 
conditions were 95°C for 3 min and 34 cycles of 
95°C for 30 seconds, 63°C for 1 min, 72°C for 
1min, and a final extension at 72°C for 10 min. 
This gave a product size of 765bp). A positive 
score was considered on agreement by two 
diagnostic tools. Where only one tool was 
positive, the score was uncertain. 
Pro-inflammatory Cytokines Typing: The single 
nucleotide polymorphisms in IL-1B (511 C/T) and 
TNF-A (_308 G/A), as well as the variable 
number of tandem repeats (VNTR) polymorphism 
of IL-1RN were assessed. The genomic human 
DNA used for genotyping was extracted from 
gastric biopsies using the QIAgen DNA extraction 
kit (QIAGEN, Hilden, Germany) according to the 
manufacturer’s instructions. 200µl DNA was 
extracted from each sample, 50µl was aliquoted 
and kept at 4
O
C for routine use and the remaining 
150µl stored at -20
O
C. From the 50ul aliquot, a 




1.10 dilution was made and all PCR experiments 
were performed on the dilution. Restriction 
endonucleases were used to digest the PCR 
products which allowed for the recognition (after 
electrophoresis) of the sequence variation between 
individuals at the recognition site. PCR-RFLP was 
set up in a 20 μl reaction which included 5 units of 
endonuclease and 15 μl of amplicon. This was 
incubated at 37
0
C for 3h. The products of RFLP 
were visualized by agarose gel electrophoresis. 
Five μl of PCR product plus 3 μl of gel loading 
buffer type was loaded into a 1% agarose in TBE 
1X buffer stained with ethidium bromide to 
visualize the PCR products. For visualizing 
enzyme digestion products 7 μl of enzyme 
digestion product plus 3μl gel loading buffer was 
used. The appropriate marker was loaded into an 
additional well. Electrophoresis was performed at 
70 V for 1h. Gels were photographed using the 
Gel Doc system (Bio-Rad). 
Genotyping of the _511 (C/T) polymorphism in 
the IL-1B gene: The polymorphism at position 
_511 of the IL-1B gene was determined by the 
PCR-restricted fragment length polymorphism 
(RFLP). The primer sequence used was; Forward 
(5’-TGGCATTGATCTGGTTCATC-3’) and 
reverse (5’GTTTAGGAATCTTCCCACTT-3’). 
Amplifications were carried out in a final volume 
of 30µl. The thermocycling conditions were: 95°C 
for 15 min; then 35 cycles of 95.5°C, 35°C and 
55°C for 1 min each, followed by 72°C  for 45sec 
and a final 72°C for 10 min. The digestion of PCR 
products was carried out at 37°C with AvaI. The 
resulting DNA fragments were resolved by 
electrophoresis on a 2.7% agarose gel stained with 
ethidium bromide. Based on restriction product 
sizes, three alleles were observed, homozygous 
allele T/T showed an intact product (304bp), 
whereas allele C/C showed products that were 
split into two, 190 and 114 bp. Heterozygous 
allele T/C had both C and T alleles. 
Genotyping of the _308 (G/A) polymorphism 
in the TNF-A gene: The polymorphism at 
position _308 of the TNF-A gene was 




GGGACACACAAGCATCAAG-3’>). The PCR 
conditions were: 95°C for 15 min and 29 cycles 
of 95.5°C for 35 sec, 60°C for 30 sec, 72°C for 
30 sec, and a final extension at 72°C for 10 min. 
The digestion of PCR products was carried out at 
37°C with E. NCO 1. The resulting DNA 
fragments were resolved by electrophoresis on a 
2.7% agarose gel stained with ethidium bromide. 
Interpretation was based on band sizes, a single 
band of 147 bp designated as homozygous allele 
TNF-α A/A, whereas a single band of 126 bp 
was allele TNF-α G/G.  If the product was split 
into two fragments 147 bp and 128 bp, it was 
designated heterozygous TNF-α G/A. 
Genotyping of the Polymorphism in the 
VNTR of the IL-1RN Gene: The polymorphic 
region within intron 2 of the IL-1RN gene was 
amplified using the following PCR conditions; 
95°C for 15 min and 34 cycles of 95.5°C for 35 
sec, 60°C for 30 sec, 72°C for 1min, and a final 
extension at 72°C for 10 min and (IL1RN1 <5’-
CCCCTCAGCAACACTCC-3’>, IL1RN2 <5’-
GGTCAGAAGGGCAGAGA-3’>) primer 
sequences. The size of the amplified product was 
determined by electrophoresis on a 2.7 % 
agarose gel stained with ethidium bromide. 
Alleles were sized relative to a 50 bp DNA 
ladder. Allele 1 (IL-1RN*1,4) was 440 bp, allele 
2 (IL-1RN*2,2) was 270 bp, allele 3 (IL-
1RN*3,5) was 530 bp, allele 4 (IL-1RN*4,3) was 
356 bp, whereas allele 5 (IL-1RN*5,6) was 616 
bp. All alleles with more than two repeats were 




H. pylori was detected with high frequency in 
patients with Gastritis, PUD and GERD implying 
a significant risk to the development of these 
pathologies (p =0.0000, p = 0.0000, p = 0.0000, 
respectively) (Table 1). 
Analysis of polymorphisms distribution in 
relation to H. pylori status (Table 2) showed that 
heterozygous allele TC of IL-1 β -511 is 
significantly associated with H. pylori infection (p 
= 0.003815). The short IL-1 RN*2/2 and the long 
allele IL-1 RN-L/L are both significantly 
associated with H. pylori infection (p = 0.0025 and 
p = 0.0203 respectively). Homozygous allele G 
and heterozygous allele G of   TNFα_308 is not 
associated with H. pylori infection in this series (p 
= 0.2051).  
 Table 1: Prevalence of H. pylori in different disease profiles 






Diagnosis   (n) Positive (%) Uncertain (%) Negative (%) P- Values 
Gastritis    (211) 115 (54.5) 6 (2.8) 90 (42.6) 0.0000 
PUD          (31) 23   (74.2) 0 (0) 8   (25.8) 0.0000 
GERD       (36) 12  (33.3) 0 (0) 24 (66.6) 0.0000 
NAM         (10) 1      (10) 1 (10) 8   (80)   
*PUD-peptic ulcer disease, GERD-gastrointestinal reflux disease, NAM- normal appearing mucosa 
 
Table 2: Interleukin 1 Polymorphisms in Relation to H. pylori Status 
 
H. pylori Status 
 Positive (151) Negative (119) Uncertain (N=20) 
IL-1 β -511 TT 63(41.7) 45(37.8) 0(0) 
  TC  49(41.2) 0(0) 
  CC  25(21) 20(100) 
IL-1RN S/S 38(25.2) 13(10.9) 0(0) 
 S/L 3(2.0) 6(5.0) 0(0) 
 L/L 110(72.8) 100(84) 20(100) 
TNFα GG 54(35.8) 36(30.3) 0(0) 
 GA 97(64.2) 81(68.1) 7(35.0) 
 AA 0(0) 2(1.7) 13(65.0) 
 
A profile of pro-inflammatory cytokines in 
relation to gastric pathologies (Table 3) reveals 
that provocative allele T of IL-1 β -511 and IL-1 
RN-L/L are more frequent in these patient groups. 
As shown in Table 3, both the homozygous IL-
1B-511T/T genotype and the heterozygous IL-1B-
511T/C genotype showed a significant association 
with gastric pathologies risk if all patients were 
included (p < 0.05). Equally IL-1 RN-L/L was 
significantly associated with gastric pathologies 
(Table 3). 
 
Table 3: Interleukin 1Polymorphisms in Different Disease Pathologies  
 
Polymorphisms Gastritis(208) GERD(n=39) GU (n=10) DU (16) GU/DU (5) Normal(10) CA(2) 
IL-1 β -511 TT 73(35.1) 17(43.6) 5(50.0) 9(56.3) 1(20.0) 3(30.0) 
 
 
TC 99(47.6) 19(48.7) 5(50.0) 4(25.0) 3(60.0) 6(60.0) 1(50.0) 
 CC 36(17.3) 3(7.7) 
 
3(18.8) 1(20.0) 1(10.0) 1(50.0) 
IL-1RN S/S 40(19.2) 3(7.7) 
 
4(25.0) 1(20.0) 1(10.0) 
 
 
S/L 7(3.4) 2(5.1) 
    
2(100.0) 
 
L/L 161(77.4) 34(87.2) 10(100.0) 12(75) 4(80.0) 9(90.0)   
TNFα GG 68(32.7) 9(23.1) 4(40.0) 3(18.8) 2(40.0) 3(30.0) 1(50.0) 
 
GA 129(62.0) 28(71.8) 6(6.0) 11(68.8) 3(60.0) 7(70.0) 1(50.0) 
 AA 11(5.3) 2(5.1)   2(12.5)       
Legend: GERD (Gastrointestinal Reflux Disease), GU (Gastric Ulcer), DU (Duodenal Ulcer) 
 
Haplotype frequency showed that haplotype T of 
IL-1 β -511 and haplotype G of   TNFα_308 are 
more prevalent in the study population. Even 
though haplotype T of IL-1 β -511 is more 
provocative, its occurrence with the less 
aggressive haplotype G of TNFα_308 waters 




down its pathological activities (Table 4). As 
shown in Table 4, haplotype analyses support the 
aetiologic role of IL-1B-511T alleles in gastric 
pathologies associated with H. pylori infection. 
 
Table 4: Frequency of IL – 1 haplotypes in Different Disease Pathologies 
 
Polymorphisms Gastritis(416) GERD(n=78) 
GU 
(n=20) DU (32) 
GU/DU 
(10) Normal(20) CA(4) 
IL-1 β-511T 245(58.9) 53(67.9) 15(75) 22(68.8) 5(50.0) 12(60) 1(25) 
IL-1 β-511C 141(41.1) 25(32.1) 5(25) 10(31.3) 5(50.0) 8(40) 3(75) 
Polymorphisms Gastritis(416) GERD(n=78) 
GU 
(n=20) DU (32) 
GU/DU 
(10) Nor(20) CA(4) 
TNF-α/G 265(63.7) 46(59) 14(70) 17(53.1) 7(70) 13(65) 3(75) 
TNF-α/A 151(36.3) 32(41.0) 6(30) 15(46.9) 3(30) 7(35) 1(25) 




H. pylori was detected with high frequency in 
patients with Gastritis, PUD and GERD implying 
a significant risk to the development of these 
pathologies (p =0.0000, p = 0.0000, p = 0.0000, 
respectively).  Analysis of polymorphisms showed 
that heterozygous allele TC of IL-1 β -511 was 
significantly associated with H. pylori infection (p 
= 0.003815). Similarly, the short IL-1 RN*2/2 and 
the long allele IL-1 RN-L/L were both 
significantly associated with H. pylori infection (p 
= 0.0025 and p = 0.0203 respectively). 
Homozygous allele G and heterozygous allele G 
of   TNFα_308 is not associated with H. pylori 
infection in this series (p = 0.2051).  IL1B-511T 
and the short IL1RN*2 have been found to be 
associated with gastric cancer risk in Caucasians 
but not in Asians (28-30). In this study IL1B-511T 
association with H. pylori gastric pathologies was 
null. However, association as established between 
gastric pathologies and heterozygous allele TC of 
IL-1 β -511. Elsewhere, Noncardia cancers have 
shown stronger associations with IL-1B -511 CT 
(31), this implies that the African population is 
likely to develop this type of cancer if infected 
with H. pylori. 
A profile of pro-inflammatory cytokines in 
relation to gastric pathologies revealed that 
provocative allele T of IL-1 β -511 and IL-1 RN-
L/L were more frequent in H. pylori associated 
gastric pathologies. The L-C-T haplotype, 
including the wild-type alleles IL-1RNL and IL-
1B-511C, has always been associated more 
frequently with controls than intestinal gastric 
cancer cases (32). Although epidemiological 
studies suggest that interleukin-1 (IL-1) genetic 
polymorphisms are involved in H. pylori-related 
gastric carcinogenesis (21, 32), in Africa; the data 
are scarce regarding the effects of these 
polymorphisms on gastric pathology. IL-1 RN-L/L 
may supply reliable disease marker estimates in 
this population given their high frequencies in this 
subgroup analysis. 
A recent study by Kimang’a et al. (22) compared 
the gene expression of the Th1-specific pro-
inflammatory cytokines IL-1α and IL-18 in 
Caucasian and African population in two distinct 
geographical regions. The Kimang’a study found 
no elevation of these cytokines in both patient 
groups, a finding that is different from other 
studies showing an induction of IL-18 or IL-1b in 
H. pylori-induced gastritis (23, 24, 25). Taking 
into consideration that IL-33 is closely related 
with respect to origin; receptor and signaling 
pathways to IL-1 and IL-18, the study investigated 
this cytokine in relation to H. pylori infection and 
did not find a differential expression of this 
cytokine in H. pylori-infected patients. Despite its 
genetic relatedness to IL-1 and IL-18, IL-33 acts 
predominately as the inducer of Th2 response 
(26). Although several studies suggest that 
Africans develop a stronger Th2 response towards 
H. pylori than other ethnicities (27), the 
expression levels of IL-33 were not different 
between H. pylori-infected versus H. pylori-





negative individuals in both study groups implying 
that a Th2-dominating profile does not play a 
major role in both Kenyan and German patients. 
Carriers of both the IL-1B-511 allele and IL-
1RN*2/2 have been reported to be at increased 
risk of hypochlorhydria and gastric cancer (8, 28). 
IL-1 genetic polymorphisms also influences H. 
pylori-related gastric mucosal IL-1beta levels and 
are related to gastric inflammation and atrophy, 
factors thought to be important in gastric 
carcinogenesis (29). Tumor necrosis factor α 
(TNFa) polymorphisms have not been 
demonstrated to affect gastric mucosal levels of 
TNFα (16), but they have been shown to affect 
gastric inflammation and cancer risk in some (12). 
Additionally, in this study, no association was 
found between TNFα and H. pylori associated 
pathologies.  
In conclusion, Allele T of IL-1 β -511 and long 
allele IL-1 RN-L/L play a role in H. pylori disease 
in this population. IL-1 RN-L/L may supply 
reliable disease marker estimates in this 
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